Rapid-Acting Insulin: a kind of insulin that starts working within 5-10 after administering the dose and is at its peak between 30 minutes to 3 hours after the dose.
Reagents: strips or even tablets that are used to check the glucose level in the blood or urine or the acetone level in the urine. They are coated with chemicals so as to change color upon use.
Rebound Hyperglycemia: a total shift to a very high level of blood glucose after being at a very low level.
Receptors: please refer to receptors.
Recognized Diabetes Education Programs: education programs on diabetes management which has been officially accepted by the American Diabetes Association.
Regular Insulin: the average insulin which shows results within 30 minutes after the injection and the peak of which is between 2-5 hours after the dose but continues working for 5-8 hours after the injection.
Renal: isrelated to the kidney. Renal failure refers to kidney failure and renal disease means kidney disease.
Renal Threshold of glucose: when the level of blood glucose is so high that kidneys let the glucose mix with the urine. It is also known as “spilling point”, “kidney threshold” or “leak point”.
Repaglinide: an oral drug used to treat type2 diabetes. It brings down the blood glucose level and enables the pancreas in making more insulin.
Retina: the center portion of the tissue that outlines the eye. It is the portion that is capable of sensing light.
Retinopathy: please refer to background retinopathy, diabetic retinopathy and proliferative retinopathy.
Risk Factor: any condition that make s a person more susceptible to a disease.
Rosiglitazone: oral drug used for the treatment of type2 diabetes. It enables the insulin to take sugar from the blood to the cells for its energy and making the cells more responsive to the insulin
